MOLBIO DIAGNOSTICS LTD (MOLBIO) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in October 2000, Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnosticscompany engaged in the research,development, manufacturing, and commercialization of rapid diagnosticsolutions.[1]

MOLBIOUpdated 17 Aug 2026, 18:54

Molbio Diagnostics Ltd

Market Cap

₹11,746Cr.

Current Price

₹1,042

High / Low

₹1,065/926

Stock P/E

80.7

Book Value
Dividend Yield0.00%
ROCE21.2%
ROE15.8%
Face Value₹1.00

About

Incorporated in October 2000, Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnosticscompany engaged in the research,development, manufacturing, and commercialization of rapid diagnosticsolutions.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days6111319417486
Inventory Days261402885393395
Days Payable12464201129226
Cash Conversion Cycle198450877438254
Working Capital Days75206479239155
ROCE %41%4%22%21%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 17 August 2026 at 18:54


Designed & Shipped by Harshit Bansal